Company Deep Dive
Business segments breakdown, earnings transcript analysis, management credibility scoring, competitive landscape, and scenario modelling.
DH
HoldBargain BinDefinitive Healthcare Corp. · Healthcare · United States · $86M · Avg Vol: $619K/d
COMPANY DESCRIPTION
Definitive Healthcare Corp. delivers comprehensive healthcare commercial intelligence data and analytics to a broad client base, including pharmaceutical, medical device, and healthcare provider organizations. The company's proprietary platform provides granular insights into healthcare professionals, facilities, and market trends, acting as a crucial decision-support tool. It is a market leader in health information services, distinguished by its extensive data coverage and advanced analytical capabilities that drive high customer retention.
FINANCIAL SUMMARY (USD)
| Year | 2022 | 2023 | 2024 | 2025 | CAGR | TTM | 2026E | 2027E | Fwd CAGR |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | 222.7M | 251.4M | 252.2M | 241.5M | 2.7% | 232.7M | 221.3M | 221.1M | -4.3% |
| EPS | -0.06 | -1.79 | -3.54 | -1.30 | — | -1.62 | — | — | — |
| Shares | 105.1M | 116.6M | 114.0M | 104.0M | -1.1% | 106.7M | — | — | — |
| Debt | 275.8M | 267.9M | 253.1M | 172.7M | -14.5% | 167.1M | — | — | — |
| Equity | 948.9M | 861.4M | 444.4M | 281.1M | -33.3% | — | — | — | — |
| Op CF | 35.6M | 41.2M | 58.2M | 53.8M | 14.8% | 41.4M | — | — | — |
| Inv CF | -248.9M | -31.8M | -26.4M | 153.9M | — | — | — | — | — |
| Fin CF | -26.7M | -25.6M | -56.7M | -150.8M | — | — | — | — | — |
SCORE BREAKDOWN
FUNDAMENTALS
SECTOR PEERS
Closest peers in Healthcare, ranked by industry match, size, and score similarity. Cross-listings of DH are excluded.
| Ticker | Company | Mkt Cap | StockRank | Signal |
|---|---|---|---|---|
| DH | Definitive Healthcare Corp.(you) | $86M | 45 | Hold |
| HCAT | Health Catalyst, Inc. | $120M | 39 | Hold |
| NURS.V | Hydreight Technologies Inc. | $147M | 59 | Hold |
| M7T.AX | Mach7 Technologies Limited | $54M | 23 | Sell |
| CCLD | CareCloud, Inc. | $106M | 77 | Buy |
| EVH | Evolent Health, Inc. | $520M | 43 | Hold |
| CARL | Carlsmed, Inc. | $461M | 40 | Hold |
| DRIO | DarioHealth Corp. | $66M | 9 | Strong Sell |
| MDRX | Veradigm Inc. | $517M | 51 | Hold |
| OPRX | OptimizeRx Corporation | $150M | 77 | Buy |
Peer medians: ROE -30.5% · P/E 27.0x · Gross margin 58.1%